查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1765050

全球细胞裂解/细胞分离市场

Cell Lysis / Cell Fractionation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球细胞裂解/细胞分馏市场规模将达到 49 亿美元

全球细胞裂解/细胞分离市场规模预计在2024年为36亿美元，预计到2030年将达到49亿美元，2024年至2030年的复合年增长率为5.6%。哺乳动物细胞是本报告分析的细分市场之一，预计其复合年增长率为6.5%，到分析期结束时规模将达到25亿美元。微生物细胞细分市场在分析期间的复合年增长率预计为5.1%。

美国市场规模估计为 9.583 亿美元，中国市场预期复合年增长率为 5.3%

美国细胞裂解/细胞分馏市场规模预计在2024年达到9.583亿美元。作为世界第二大经济体，中国预计2030年市场规模将达到7.746亿美元，2024-2030年的复合年增长率为5.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为5.2%和4.6%。在欧洲，预计德国的复合年增长率为4.2%。

全球细胞裂解/细胞分馏市场－主要趋势与驱动因素摘要

细胞裂解对于解答生物学问题是否至关重要？

细胞裂解是生物学研究中的基本技术，对于破坏细胞以释放其内部内容物（包括蛋白质、DNA、RNA 和细胞器）至关重要。这个过程是许多实验工作流程中关键的第一步，包括基因组学、蛋白质组学和代谢代谢体学，在这些实验中，分析细胞成分对于了解生物过程、疾病机制和治疗标靶是必不可少的。细胞裂解可以透过机械、化学或酶方法来实现，这取决于被裂解细胞的类型和下游应用。超音波和均质化等机械方法通常用于破坏坚固的细胞类型，例如细菌和植物细胞，而溶菌酶处理等酶促方法则常用于更精细的样品，以确保精细的生物分子得以保存。细胞裂解的成功直接影响所得细胞级分的质量，因此选择正确的方法至关重要。多年来，裂解技术的创新提高了细胞内容物的产量和纯度。这在蛋白质精製和用于序列测定的核酸萃取等高精度应用中尤其重要。因此，细胞破碎仍然是研究和工业生物生产中的重要工具，使科学家能够在分子层面上解剖和理解生命的内部运作。

为什么细胞分离对于研究亚细胞结构至关重要？

细胞分离是细胞裂解后分离细胞成分的过程，对于研究单一细胞器和大分子的功能和结构至关重要。细胞裂解后，使用离心等分离技术分离各种亚细胞成分，例如细胞核、粒线体、内质网和细胞质。这对于理解能量产生、蛋白质合成和细胞凋亡等细胞过程尤其重要，因为在这些过程中必须分离和研究特定细胞器的作用。超速离心和密度梯度分离技术的进步使得这些成分的分离更加精确，使研究人员能够详细研究它们的生化特性和相互作用。细胞分离在神经生物学和癌症研究等领域至关重要，因为细胞器的行为极大地影响疾病的进展和治疗反应。此外，细胞分离也广泛应用于药物研发，因为分离细胞器可以帮助科学家更深入了解药物的作用机制和代谢途径，最终开发出更有针对性的治疗方法。随着亚细胞分析需求的增加，细胞分馏技术不断发展，以支持各个生物医学领域对细胞成分的详细探索。

技术进步如何影响细胞裂解和分馏？

技术创新极大地改变了细胞​​裂解和分离的格局，使这些过程更加高效、可扩展且精确。其中最显着的进展之一是自动化系统的开发，该系统能够实现高通量细胞裂解，从而简化了药物研发和基因组学等大规模研究的工作流程。这些自动化系统最大限度地减少了人为错误并降低了差异性。这在处理精细样品或需要确保多个实验之间一致性时至关重要。此外，电穿孔和压力循环技术等新型非机械裂解技术应运而生，为传统方法提供了更为温和的替代方案，并降低了蛋白质变性和脆弱细胞成分受损的风险。这些创新在蛋白质体学中尤其重要，因为保持蛋白质完整性对于下游分析至关重要。在分离方面，微射流的进步使得在微尺度上更精确地分离细胞成分成为可能，减少了样品损失并提高了组件纯度。这为单细胞分析打开了新的大门，在单细胞分析中，微量的细胞物质必须格外小心处理。此外，将机器学习演算法融入分离过程，提高了我们根据特定细胞特征预测和优化分离结果的能力。此类进展正在推动该领域的发展，确保细胞裂解和分离始终处于分子生物学研究的前沿。

是什么推动了细胞裂解和分馏市场的成长？

细胞裂解和分离市场的成长受到多种因素的推动，包括生物技术的进步、个人化医疗需求的不断增长以及蛋白质组学和基因组学研究范围的不断扩大。随着生物製药产业持续开发标靶治疗，尤其是针对癌症和神经退化性疾病的疗法，对高精度细胞裂解和分离工具的需求呈指数级增长。自动化高通量裂解系统等技术进步使研究人员能够更快速且有效率地处理大量样本，这在药物研发和临床诊断等领域至关重要。单细胞分析日益受到关注，这需要研究人员分离和分析单一细胞的内容物，这也推动了对更复杂的裂解和分离技术的需求。此外，蛋白质体学在理解复杂生物系统方面的兴起，也推动了对能够准确分离和保存蛋白质复合物的先进分离技术的需求。消费行为也发挥作用，因为患者和医疗保健提供者正在寻求更个人化、更精准的治疗方案，而这些方案依赖这些技术提供的详细细胞和分子数据。此外，製药业对生技药品生产和品管的监管要求，也推动了强大的细胞裂解和分离解决方案的应用，以确保药物生产流程符合严格的标准。这些因素，加上生命科学研究投资的不断增加，预计将在未来几年推动细胞裂解和分离市场的成长。

部分

组件（消耗品、设备）、类型（哺乳动物细胞、微生物细胞、其他类型）、最终用户（研究机构/实验室、製药/生物技术公司、其他最终用户）

受访公司范例

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • Qiagen NV
  • Qsonica LLC
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP10947

Global Cell Lysis / Cell Fractionation Market to Reach US$4.9 Billion by 2030

The global market for Cell Lysis / Cell Fractionation estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Mammalian Cells, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Microbial Cells segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$958.3 Million While China is Forecast to Grow at 5.3% CAGR

The Cell Lysis / Cell Fractionation market in the U.S. is estimated at US$958.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$774.6 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.2% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Cell Lysis / Cell Fractionation Market - Key Trends and Drivers Summarized

How Is Cell Lysis Essential to Unlocking Biological Research?

Cell lysis is a foundational technique in biological research, essential for breaking open cells to release their internal contents, such as proteins, DNA, RNA, and organelles. This process is a critical first step in many experimental workflows, including genomics, proteomics, and metabolomics, where the analysis of cellular components is required to understand biological processes, disease mechanisms, and therapeutic targets. Cell lysis can be achieved through mechanical, chemical, or enzymatic methods, depending on the type of cells being lysed and the downstream application. Mechanical methods, such as sonication or homogenization, are often used to disrupt tougher cell types like bacterial or plant cells, while enzymatic approaches, like lysozyme treatment, are common for more delicate samples, ensuring the preservation of sensitive biomolecules. The success of cell lysis directly impacts the quality of the resulting cellular fractions, which makes choosing the appropriate method crucial. Over the years, innovations in lysis techniques have improved the yield and purity of cellular contents, which is particularly important in high-precision applications like protein purification and nucleic acid extraction for sequencing. Cell lysis, therefore, remains a vital tool in both research and industrial bioproduction, allowing scientists to dissect and understand the inner workings of life at a molecular level.

Why Is Cell Fractionation Crucial for Studying Subcellular Structures?

Cell fractionation, the process of separating cellular components after lysis, is indispensable for studying the function and structure of individual organelles and macromolecules. Once the cells have been lysed, fractionation techniques, such as centrifugation, are used to separate the various subcellular components like the nucleus, mitochondria, endoplasmic reticulum, and cytoplasm. This is particularly important in understanding cellular processes such as energy production, protein synthesis, and apoptosis, where the roles of specific organelles must be examined in isolation. Advances in ultracentrifugation and density gradient fractionation have enabled more precise isolation of these components, allowing researchers to study their biochemical properties and interactions in great detail. In fields like neurobiology and cancer research, where the behavior of cellular organelles can significantly influence disease progression and treatment responses, cell fractionation is essential. Moreover, cell fractionation has wide applications in the development of pharmaceuticals, as isolating organelles allows scientists to better understand drug mechanisms and metabolic pathways, ultimately guiding the development of more targeted therapies. As the need for subcellular analysis grows, cell fractionation continues to evolve, supporting the detailed exploration of cellular components in various biomedical fields.

How Are Technological Innovations Shaping Cell Lysis and Fractionation?

Technological innovations have dramatically transformed the landscape of cell lysis and fractionation, making these processes more efficient, scalable, and precise. One of the most notable advancements is the development of automated systems that allow for high-throughput cell lysis, streamlining workflows in large-scale studies such as drug discovery and genomic research. These automated systems minimize human error and reduce variability, which is crucial when working with sensitive samples or when consistency is required across multiple experiments. Additionally, novel non-mechanical lysis techniques, such as electroporation and pressure cycling technology, have emerged, offering gentler alternatives to traditional methods and reducing the risk of protein denaturation or damage to fragile cellular components. These innovations are particularly valuable in proteomics, where maintaining the integrity of proteins is critical for downstream analysis. On the fractionation front, advancements in microfluidics have enabled more precise separation of cellular components at the microscale, reducing sample loss and improving the purity of the fractions. This has opened new doors for single-cell analysis, where tiny amounts of cellular material must be handled with extreme care. Moreover, the integration of machine learning algorithms into fractionation processes is enhancing the ability to predict and optimize fractionation outcomes based on specific cellular characteristics. These technological developments are driving the field forward, ensuring that cell lysis and fractionation remain at the cutting edge of molecular biology research.

What Is Driving Growth in the Cell Lysis and Fractionation Market?

The growth in the cell lysis and fractionation market is driven by several factors, including advancements in biotechnology, rising demand for personalized medicine, and the expanding scope of proteomics and genomics research. As the biopharmaceutical industry continues to develop targeted therapies, particularly for cancer and neurodegenerative diseases, the need for high-precision cell lysis and fractionation tools has grown exponentially. Technological advancements, such as automated and high-throughput lysis systems, are making it easier for researchers to process large numbers of samples quickly and efficiently, which is critical in fields like drug discovery and clinical diagnostics. The increasing focus on single-cell analysis, where researchers need to isolate and analyze the contents of individual cells, is also driving demand for more sophisticated lysis and fractionation technologies. Additionally, the rise of proteomics in understanding complex biological systems is fueling the need for advanced fractionation techniques that can isolate and preserve protein complexes with high fidelity. Consumer behavior is also playing a role, as patients and healthcare providers push for more personalized and precise treatment options, which depend on the detailed cellular and molecular data that these technologies provide. Furthermore, regulatory requirements for biologics production and quality control in the pharmaceutical industry are encouraging the adoption of robust cell lysis and fractionation solutions to ensure that drug manufacturing processes meet stringent standards. These factors, coupled with increased investment in life sciences research, are expected to continue driving the growth of the cell lysis and fractionation market in the coming years.

SCOPE OF STUDY:

The report analyzes the Cell Lysis / Cell Fractionation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Consumables, Instruments); Type (Mammalian Cells, Microbial Cells, Other Types); End-Use (Research Laboratories & Institutes, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • Qiagen NV
  • Qsonica L.L.C.
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Cell Lysis / Cell Fractionation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Proteomics and Genomics Expands Market for Cell Lysis Solutions
    • Advancements in Non-Mechanical Lysis Technologies Propel Innovation in Cell Fractionation
    • Increasing Use of Cell Lysis in Drug Discovery Strengthens Market Growth
    • Growing Adoption of Cell Fractionation in Cancer Research Drives Demand for Advanced Lysis Techniques
    • Technological Innovations in Microfluidic-Based Lysis Create New Opportunities in Cell Fractionation
    • Expansion of Single-Cell Analysis Boosts the Need for Gentle and Precise Cell Lysis Methods
    • Rising Investment in Biopharmaceutical Research Fuels Growth in Cell Lysis Technologies
    • Growing Application of Cell Lysis in Protein Purification Accelerates Market Growth
    • Advances in Enzyme-Based Lysis Methods Drive Innovation in Cell Fractionation
    • Rising Demand for Efficient Organelle Isolation Techniques Expands Opportunities in Cell Fractionation
    • Emergence of Automated Lysis Systems Enhances Efficiency and Scalability in Research Applications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Mammalian Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Mammalian Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Microbial Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Microbial Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Research Laboratories & Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Cell Lysis / Cell Fractionation Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Cell Lysis / Cell Fractionation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: France 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Germany 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Italy 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: UK 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of World 6-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2025 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION